Loading...

Giselle M Petzinger, MD

Title(s)Associate Professor of Neurology (Clinical Scholar)
AddressHCC 3000
Health Sciences Campus
Los Angeles CA 90089-9405
Phone+1 323 442 5728
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Petzinger is a board certified neurologist specializing in the care of patients with Parkinson’s disease. She divides her time between clinical care of patients and laboratory research. The primary focus of Dr. Petzinger’s research is to better understand how to promote brain repair following injury and to translate these findings into new therapeutic treatments. Dr. Petzinger has been involved in numerous federally funded research grants. Currently, she is the principal investigator on the US Army Research Grant entitled Behaviorial and Pharmacolgical Enhancement of Neuroplasticity in Basal Ganglia of the MPTP-Lesioned Mouse and Non-Human Primate.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease. Int J Geriatr Psychiatry. 2020 Apr; 35(4):396-404. Petkus AJ, Filoteo JV, Schiehser DM, Gomez ME, Hui JS, Jarrahi B, McEwen S, Jakowec MW, Petzinger GM. PMID: 31894601.
      View in: PubMed   Mentions:    Fields:    
    2. Treadmill exercise rescues mitochondrial function and motor behavior in the CAG140 knock-in mouse model of Huntington's disease. Chem Biol Interact. 2020 Jan 05; 315:108907. Caldwell CC, Petzinger GM, Jakowec MW, Cadenas E. PMID: 31778667.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    3. Intensive treadmill exercise increases expression of hypoxia-inducible factor 1a and its downstream transcript targets: a potential role in neuroplasticity. Neuroreport. 2019 06 12; 30(9):619-627. Halliday MR, Abeydeera D, Lundquist AJ, Petzinger GM, Jakowec MW. PMID: 31045849.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    4. Exercise induces region-specific remodeling of astrocyte morphology and reactive astrocyte gene expression patterns in male mice. J Neurosci Res. 2019 09; 97(9):1081-1094. Lundquist AJ, Parizher J, Petzinger GM, Jakowec MW. PMID: 31175682.
      View in: PubMed   Mentions:    Fields:    
    5. Worse cognitive performance predicts increased anxiety and depressive symptoms in patients with Parkinson's disease: A bidirectional analysis. Neuropsychology. 2019 Jan; 33(1):35-46. Petkus AJ, Filoteo JV, Schiehser DM, Gomez ME, Petzinger G. PMID: 30335414.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson's disease rehabilitation. Neurosci Biobehav Rev. 2018 07; 90:294-308. Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G. PMID: 29733882.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. The Oxygen Paradox, the French Paradox, and age-related diseases. Geroscience. 2017 12; 39(5-6):499-550. Davies JMS, Cillard J, Friguet B, Cadenas E, Cadet J, Cayce R, Fishmann A, Liao D, Bulteau AL, Derbré F, Rébillard A, Burstein S, Hirsch E, Kloner RA, Jakowec M, Petzinger G, Sauce D, Sennlaub F, Limon I, Ursini F, Maiorino M, Economides C, Pike CJ, Cohen P, Salvayre AN, Halliday MR, Lundquist AJ, Jakowec NA, Mechta-Grigoriou F, Mericskay M, Mariani J, Li Z, Huang D, Grant E, Forman HJ, Finch CE, Sun PY, Pomatto LCD, Agbulut O, Warburton D, Neri C, Rouis M, Cillard P, Capeau J, Rosenbaum J, Davies KJA. PMID: 29270905.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson's disease. Neuroreport. 2017 Oct 18; 28(15):987-995. Kintz N, Petzinger GM, Jakowec MW. PMID: 28877102.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    9. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington's disease. Neurobiol Dis. 2017 Sep; 105:15-32. Stefanko DP, Shah VD, Yamasaki WK, Petzinger GM, Jakowec MW. PMID: 28502806.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. Noradrenergic mechanisms of arousal's bidirectional effects on episodic memory. Neurobiol Learn Mem. 2017 Jan; 137:1-14. Clewett D, Sakaki M, Nielsen S, Petzinger G, Mather M. PMID: 27815214.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Engaging cognitive circuits to promote motor recovery in degenerative disorders. exercise as a learning modality. J Hum Kinet. 2016 Sep 01; 52:35-51. Jakowec MW, Wang Z, Holschneider D, Beeler J, Petzinger GM. PMID: 28149392.
      View in: PubMed   Mentions:
    12. Evidence of functional brain reorganization on the basis of blood flow changes in the CAG140 knock-in mouse model of Huntington's disease. Neuroreport. 2016 06 15; 27(9):632-9. Wang Z, Stefanko DP, Guo Y, Toy WA, Petzinger GM, Jakowec MW, Holschneider DP. PMID: 27082842.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    13. Context-Dependent Learning in People With Parkinson's Disease. J Mot Behav. 2016 May-Jun; 48(3):240-8. Lee YY, Winstein CJ, Gordon J, Petzinger GM, Zelinski EM, Fisher BE. PMID: 26375786.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Personality traits and the risk for Parkinson disease: a prospective study. Eur J Epidemiol. 2016 Feb; 31(2):169-75. Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, Pedersen NL, Wirdefeldt K. PMID: 26130127.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    15. The Effects of Exercise on Dopamine Neurotransmission in Parkinson's Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry. Brain Plast. 2015; 1(1):29-39. Petzinger GM, Holschneider DP, Fisher BE, McEwen S, Kintz N, Halliday M, Toy W, Walsh JW, Beeler J, Jakowec MW. PMID: 26512345.
      View in: PubMed   Mentions:
    16. A kinder, gentler dopamine… highlighting dopamine's role in behavioral flexibility. Front Neurosci. 2014; 8:4. Beeler JA, Cools R, Luciana M, Ostlund SB, Petzinger G. PMID: 24478624.
      View in: PubMed   Mentions:
    17. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiol Dis. 2014 Mar; 63:201-9. Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, Vuckovic MG, Jakowec MW. PMID: 24316165.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    18. The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson's Disease. Front Neurol. 2013; 4:134. Beeler JA, Petzinger G, Jakowec MW. PMID: 24062721.
      View in: PubMed   Mentions:
    19. Exercise modifies a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse. J Neurosci Res. 2013 Nov; 91(11):1492-507. Kintz N, Petzinger GM, Akopian G, Ptasnik S, Williams C, Jakowec MW, Walsh JP. PMID: 23918451.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    20. Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease. Neuroreport. 2013 Jul 10; 24(10):509-14. Fisher BE, Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW, Petzinger GM. PMID: 23636255.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    21. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease. Lancet Neurol. 2013 Jul; 12(7):716-26. Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW. PMID: 23769598.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansAnimalsCells
    22. Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat. Neuroscience. 2012 Jul 26; 215:149-59. Akopian G, Crawford C, Petzinger G, Jakowec MW, Walsh JP. PMID: 22554779.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    23. Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers. Neuroepidemiology. 2012; 38(3):186-93. Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, Lew MF, Pedersen NL, Wirdefeldt K. PMID: 22472568.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    24. How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol. 2011 Jul 12; 7(9):528-34. Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, Bloem BR. PMID: 21750523.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    25. MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse. Parkinsons Dis. 2011; 2011:138471. Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI. PMID: 21765998.
      View in: PubMed   Mentions:
    26. The role of exercise in facilitating basal ganglia function in Parkinson's disease. Neurodegener Dis Manag. 2011 Apr 01; 1(2):157-170. Petzinger GM, Fisher BE, Akopian G, Holschneider DP, Wood R, Walsh JP, Lund B, Meshul C, Vuckovic M, Jakowec MW. PMID: 23805167.
      View in: PubMed   Mentions: 3     Fields:    
    27. Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [¹8F]fallypride. Mov Disord. 2010 Dec 15; 25(16):2777-84. Vuckovic MG, Li Q, Fisher B, Nacca A, Leahy RM, Walsh JP, Mukherjee J, Williams C, Jakowec MW, Petzinger GM. PMID: 20960487.
      View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
    28. Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia. Synapse. 2011 Apr; 65(4):339-50. Crawford CA, Akopian G, Ring J, Jakowec MW, Petzinger GM, Andersen JK, Vittozzi-Wong P, Wang K, Farley CM, Charntikov S, Mitroi D, Beal MF, Chow R, Walsh JP. PMID: 20730800.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    29. Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse. Behav Brain Res. 2010 Dec 01; 213(2):253-62. Gorton LM, Vuckovic MG, Vertelkina N, Petzinger GM, Jakowec MW, Wood RI. PMID: 20472000.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    30. Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease. Pharmacol Biochem Behav. 2010 Jun; 95(4):466-72. Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI. PMID: 20347863.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    31. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci Res. 2010 Feb 15; 88(3):650-68. VanLeeuwen JE, Petzinger GM, Walsh JP, Akopian GK, Vuckovic M, Jakowec MW. PMID: 19746427.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    32. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S141-5. Petzinger GM, Fisher BE, Van Leeuwen JE, Vukovic M, Akopian G, Meshul CK, Holschneider DP, Nacca A, Walsh JP, Jakowec MW. PMID: 20187247.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    33. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease. Neurorehabil Neural Repair. 2009 Sep; 23(7):657-61. Song J, Fisher BE, Petzinger G, Wu A, Gordon J, Salem GJ. PMID: 19336530.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia. J Neurosci. 2008 Sep 17; 28(38):9585-97. Akopian G, Crawford C, Beal MF, Cappelletti M, Jakowec MW, Petzinger GM, Zheng L, Gheorghe SL, Reichel CM, Chow R, Walsh JP. PMID: 18799690.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    35. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiol Dis. 2008 Nov; 32(2):319-27. Vuckovic MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM, Jakowec MW. PMID: 18718537.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    36. The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease. Arch Phys Med Rehabil. 2008 Jul; 89(7):1221-9. Fisher BE, Wu AD, Salem GJ, Song J, Lin CH, Yip J, Cen S, Gordon J, Jakowec M, Petzinger G. PMID: 18534554.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    37. Asymmetric corticomotor excitability correlations in early Parkinson's disease. Mov Disord. 2007 Aug 15; 22(11):1587-93. Wu AD, Petzinger GM, Lin CH, Kung M, Fisher B. PMID: 17523196.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    38. Complete ascertainment of Parkinson disease in the Swedish Twin Registry. Neurobiol Aging. 2008 Dec; 29(12):1765-73. Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, Pedersen NL. PMID: 17532098.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    39. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci. 2007 May 16; 27(20):5291-300. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW. PMID: 17507552.
      View in: PubMed   Mentions: 93     Fields:    Translation:AnimalsCells
    40. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins. J Neurosci Res. 2006 Feb 01; 83(2):332-47. Petzinger GM, Fisher B, Hogg E, Abernathy A, Arevalo P, Nixon K, Jakowec MW. PMID: 16385585.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    41. High and low responders to novelty show differential effects in striatal glutamate. Synapse. 2005 Dec 01; 58(3):200-7. Shakil SS, Holmer HK, Moore C, Abernathy AT, Jakowec MW, Petzinger GM, Meshul CK. PMID: 16138315.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    42. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. Comp Med. 2004 Oct; 54(5):497-513. Jakowec MW, Petzinger GM. PMID: 15575363.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    43. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res. 2004 Aug 01; 77(3):378-90. Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW. PMID: 15248294.
      View in: PubMed   Mentions: 80     Fields:    Translation:Animals
    44. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. J Neurosci Res. 2004 May 15; 76(4):539-50. Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM. PMID: 15114626.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    45. Human neural stem cell transplantation in the MPTP-lesioned mouse. Brain Res. 2003 May 09; 971(2):168-77. Liker MA, Petzinger GM, Nixon K, McNeill T, Jakowec MW. PMID: 12706233.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    46. Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD. Neurology. 2002 May 14; 58(9):1435-6. Woulfe JM, Duke R, Middeldorp JM, Stevens S, Vervoort M, Hashimoto M, Masliah E, Chan P, Di Monte DA, Langston JW, Petzinger G, Hoogendoorn H, Munoz DG. PMID: 12011302.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    47. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem. 2001 Mar; 76(5):1265-74. Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M. PMID: 11238711.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansAnimals
    48. Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate. Mov Disord. 2001 Mar; 16(2):202-7. Petzinger GM, Quik M, Ivashina E, Jakowec MW, Jakubiak M, Di Monte D, Langston JW. PMID: 11295771.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    49. Postnatal expression of alpha-synuclein protein in the rodent substantia nigra and striatum. Dev Neurosci. 2001; 23(2):91-9. Jakowec MW, Donaldson DM, Barba J, Petzinger GM. PMID: 11509831.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    50. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Mov Disord. 2000 May; 15(3):459-66. Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ. PMID: 10830409.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    51. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology. 2000 Apr 11; 54(7):1498-504. Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, Silverberg GD, Möller HJ, Yesavage JA, Tinklenberg JR, Shooter EM, Murphy GM. PMID: 10751266.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    52. Investigating levodopa-induced dyskinesias in the parkinsonian primate. Ann Neurol. 2000 Apr; 47(4 Suppl 1):S79-89. Langston JW, Quik M, Petzinger G, Jakowec M, Di Monte DA. PMID: 10762135.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    53. Experimental models of Parkinson's disease: insights from many models. Lab Anim Sci. 1999 Aug; 49(4):363-71. Tolwani RJ, Jakowec MW, Petzinger GM, Green S, Waggie K. PMID: 10480640.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    54. The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls. Neurosci Lett. 1998 Aug 28; 253(1):13-6. Jakowec MW, Petzinger GM, Sastry S, Donaldson DM, McCormack A, Langston JW. PMID: 9754793.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    55. A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment. Mov Disord. 1997 Mar; 12(2):246-8. Petzinger GM, Bressman SB. PMID: 9087987.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol. 1996 Dec; 53(12):1241-6. Ford B, Greene P, Louis ED, Petzinger G, Bressman SB, Goodman R, Brin MF, Sadiq S, Fahn S. PMID: 8970452.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    57. Fentanyl-induced dyskinesias. Mov Disord. 1995 Sep; 10(5):679-80. Petzinger G, Mayer SA, Przedborski S. PMID: 8552126.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Potential misidentification of trichlorophenylethanol in imported peppers. Rapid Commun Mass Spectrom. 1990 Feb; 4(2):58-60. Cairns T, Siegmund EG, Barry TL, Petzinger G. PMID: 2134339.
      View in: PubMed   Mentions:    Fields:    Translation:PHPublic Health
    59. Thermospray mass spectrometry of thiazides. A novel elimination and rearrangement resulting from a molecular adduct ion. Rapid Commun Mass Spectrom. 1988 Feb; 2(2):25-7. Cairns T, Siegmund EG, Stamp JJ, Barry TL, Petzinger G. PMID: 2577840.
      View in: PubMed   Mentions:    Fields:    
    Giselle's Networks
    Concepts (288)
    Derived automatically from this person's publications.
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _